Roger D. Dansey
2020
In 2020, Roger D. Dansey earned a total compensation of $7.1M as Chief Medical Officer at Seattle Genetics, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $3,258,442 |
|---|---|
| Non-Equity Incentive Plan | $759,300 |
| Option Awards | $2,150,516 |
| Salary | $711,467 |
| Other | $181,812 |
| Total | $7,061,537 |
Dansey received $3.3M in bonus, accounting for 46% of the total pay in 2020.
Dansey also received $759.3K in non-equity incentive plan, $2.2M in option awards, $711.5K in salary and $181.8K in other compensation.
Rankings
In 2020, Roger D. Dansey's compensation ranked 1,376th out of 13,090 executives tracked by ExecPay. In other words, Dansey earned more than 89.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,376 out of 13,090 | 90th |
Division Manufacturing | 504 out of 5,620 | 91st |
Major group Chemicals And Allied Products | 182 out of 2,253 | 92nd |
Industry group Drugs | 154 out of 1,953 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 44 out of 411 | 89th |
Source: SEC filing on March 30, 2022.
Dansey's colleagues
We found four more compensation records of executives who worked with Roger D. Dansey at Seattle Genetics in 2020.